home

Chinese scientist YouYou Tu was awarded the 2015 Nobel Prize in Physiology or Medicine

CommentsPharmacodia.com2015-10-06 00:00 Read   642

the 2015 Nobel Prize in Physiology or Medicine

Analyst sees big things for Allergan, Amgen despite slow growth in China and biosimilar pressures

CommentsPharmacodia.com2015-10-05 00:00 Read   314

The media blitz over jacked-up drug prices and concerns over slowing growth in China may have temporarily kicked the breath out of pharma valuations, but some analysts think the concerns will be short-lived and a return to growth is inevitable.

FTC weighs in on Mylan case, saying generics tweaking may be anticompetitive

CommentsPharmacodia.com2015-10-05 00:00 Read   333

Generics makers have had just about enough with branded drugmakers tweaking aging meds to hold on to sales, with some arguing in court that the move is inherently anticompetitive. Now the FTC is wading into the debate, saying that pharma companies that make small changes to brand-name products to ward off competition from cheaper copycats may be violating antitrust laws.

Ackman's Pershing Square off 12.6 pct for year after Valeant tumble

CommentsPharmacodia.com2015-10-05 00:00 Read   259

Billionaire hedge fund manager William Ackman's Pershing Square Holdings fund is nursing a 12.6 percent loss for 2015, an investor who received Ackman's letter on Thursday said, marking a dramatic reversal of fortune for one of last year's best performing managers.

With promising RSV data in hand, Novavax wins $89M Gates grant for PhIII

CommentsPharmacodia.com2015-09-30 00:00 Read   194

Immunizing pregnant women with an RSV vaccine charged up levels of antibodies that should be able to protect infants during the first few months of their lives, Novavax reported Tuesday morning, adding that the Bill & Melinda Gates Foundation followed up with an $89 million grant to fund a pivotal study.

U.S. cancer drug prices up to 3X higher than in Europe: Study

CommentsPharmacodia.com2015-09-25 00:00 Read   352

Amid all the drug-pricing brouhaha this week, a British pharmacologist was preparing to unveil his research showing just how much more Americans pay for cancer therapies. And while it's well known that medications cost more in the U.S. than in other countries, this new study puts some surprising numbers to that spread.

FDA asks Pfizer for Zoloft label update highlighting birth defect risks

CommentsPharmacodia.com2015-09-19 00:00 Read   252

For years, Pfizer ($PFE) has shrugged off claims that its antidepressant Zoloft causes heart defects in newborns, fighting a raft of litigation alleging that the company did not adequately warn pregnant women taking the med about its potential risks. Now the FDA is weighing in on the issue, asking the company to acknowledge some studies that link Zoloft to heart defects in babies.